PUR — Pure Biologics SA Balance Sheet
0.000.00%
- PLN17.96m
- PLN29.91m
Annual balance sheet for Pure Biologics SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | PAS | PAS | PAS | PAS | PAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 8.96 | 32.9 | 7.18 | 3.61 | 0.313 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.35 | 9.29 | 15.2 | 14.7 | 1.67 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 13 | 43 | 24.2 | 18.8 | 2.09 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4.88 | 3.45 | 8.42 | 0.881 | 0.12 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 18.9 | 47.2 | 33 | 22.7 | 2.34 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 18 | 5.55 | 12.8 | 7.21 | 15.4 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 21.8 | 7.7 | 14.7 | 20.8 | 15.5 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -2.89 | 39.5 | 18.3 | 1.89 | -13.1 |
Total Liabilities & Shareholders' Equity | 18.9 | 47.2 | 33 | 22.7 | 2.34 |
Total Common Shares Outstanding |